EPISODE · Dec 28, 2022 · 4 MIN
FDA D.I.S.C.O. Burst Edition: FDA approves a new dosing regimen for asparaginase erwinia chrysanthemi (recombinant)
from FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) · host U.S. Food and Drug Administration, Center for Drug Evaluation and Research
Listen to a soundcast of the November 18, 2022 FDA approval of a new dosing regimen for asparaginase erwinia chrysanthemi (recombinant).
Embed this episode
Ready to play
FDA D.I.S.C.O. Burst Edition: FDA approves a new dosing regimen for asparaginase erwinia chrysanthemi (recombinant)
0:00
4:00
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)?
This episode is 4 minutes long.
When was this FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) episode published?
This episode was published on December 28, 2022.
Can I download this FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!